Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centralized Health System Interventions to Enhance Reach
NCT04199117Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Mar 2020
- Primary completion
- Oct 2024
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (16 arms), sponsored by University of Wisconsin–Madison. Primary endpoints: Number of Participants Who Initiate Treatment Over 1 Year of Study Enrollment and Number of Participants Who Initiate Treatment Over 2 Years of Study Enrollment. Started Mar 2020; status: completed.
Beyond the preview
Go deeper on NCT04199117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199117.